novo nordisk fda semaglutide has officially filed for approval of CagriSema, a powerful new once-weekly injection that combines a GLP-1 receptor agonist with an amylin analogue, setting the stage for the next major The FDA has issued a

Although patent 780 specifically claims the method of treating diabetes mellitus, it also discloses how the compounds, including tirzepatide, can be used to treat other indications, including obesity and increasing bone strength

Medicines in the semaglutide family (GLP-1 agonists) are being studied to see what role they might have in reducing the risk of other chronic problems such as heart disease, which often occur in tandem with obesity

Prozac is taken orally and is available in a tablet, capsule, or liquid

The foods to minimize on GLP-1 medications include high-fat items that worsen nausea and high-sugar foods that counteract the blood sugar benefits

They can make new semaglutide and tirzepatide medications that are not officially considered copies of the brand-name drugs by significantly altering a drug's dosage, ingredients, or form